Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Avril

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
International Journal of Radiation Oncology, Biology, Physics|June 6, 2006
Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancersRegiane S Andrade, Dwight E Heron, Berna Degirmenci, et al.
European Journal of Endocrinology|March 10, 2010
Single photon emission computed tomography (SPECT)/computed tomography using Iodine-123 in patients with differentiated thyroid cancer: additional value over whole body planar imaging and SPECTTara Barwick, Iain Murray, Hakim Megadmi, et al.
Journal of Gastrointestinal Oncology|May 18, 2023
The predictive impact of dual somatostatin receptor/fluorodeoxyglucose (FDG) positron emission tomography (PET) in metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs): review of literature and a single institution experienceAmr Mohamed, Sylvia L Asa, Zhenghong Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucoseJörg Schwarz-Dose, Michael Untch, Reinhold Tiling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2014
Repeatability of quantitative FDG-PET/CT and contrast-enhanced CT in recurrent ovarian carcinoma: test-retest measurements for tumor FDG uptake, diameter, and volumeAndrea G Rockall, Norbert Avril, Raymond Lam, et al.
Clinical Endocrinology|April 9, 2008
123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlationKunwar S S Bhatia, Mohamed M Ismail, Anju Sahdev, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 23, 2020
Liver background uptake of [<sup>18</sup>F]FLT in PET imagingOlga Sergeeva, Yifan Zhang, Jonathan Kenyon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 3, 2007
18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancerAmer Shammas, Berna Degirmenci, James M Mountz, et al.
Molecular Imaging and Biology|June 12, 2014
GRP receptor imaging of prostate cancer using [(99m)Tc]Demobesin 4: a first-in-man studyStephen J Mather, Berthold A Nock, Theodosia Maina, et al.
Neuro-Oncology Advances|February 1, 2020
MCT4 regulates de novo pyrimidine biosynthesis in GBM in a lactate-independent mannerRaffaella Spina, Dillon M Voss, Xiaohua Yang, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
International Journal of Radiation Oncology, Biology, Physics|June 6, 2006
Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancersRegiane S Andrade, Dwight E Heron, Berna Degirmenci, et al.
European Journal of Endocrinology|March 10, 2010
Single photon emission computed tomography (SPECT)/computed tomography using Iodine-123 in patients with differentiated thyroid cancer: additional value over whole body planar imaging and SPECTTara Barwick, Iain Murray, Hakim Megadmi, et al.
Journal of Gastrointestinal Oncology|May 18, 2023
The predictive impact of dual somatostatin receptor/fluorodeoxyglucose (FDG) positron emission tomography (PET) in metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs): review of literature and a single institution experienceAmr Mohamed, Sylvia L Asa, Zhenghong Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucoseJörg Schwarz-Dose, Michael Untch, Reinhold Tiling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2014
Repeatability of quantitative FDG-PET/CT and contrast-enhanced CT in recurrent ovarian carcinoma: test-retest measurements for tumor FDG uptake, diameter, and volumeAndrea G Rockall, Norbert Avril, Raymond Lam, et al.
Clinical Endocrinology|April 9, 2008
123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlationKunwar S S Bhatia, Mohamed M Ismail, Anju Sahdev, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 23, 2020
Liver background uptake of [<sup>18</sup>F]FLT in PET imagingOlga Sergeeva, Yifan Zhang, Jonathan Kenyon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 3, 2007
18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancerAmer Shammas, Berna Degirmenci, James M Mountz, et al.
Molecular Imaging and Biology|June 12, 2014
GRP receptor imaging of prostate cancer using [(99m)Tc]Demobesin 4: a first-in-man studyStephen J Mather, Berthold A Nock, Theodosia Maina, et al.
Neuro-Oncology Advances|February 1, 2020
MCT4 regulates de novo pyrimidine biosynthesis in GBM in a lactate-independent mannerRaffaella Spina, Dillon M Voss, Xiaohua Yang, et al.
Pageof 8